ZIMVIE INC (ZIMV)
US98888T1079 - Common Stock
Overall ZIMV gets a fundamental rating of 2 out of 10. We evaluated ZIMV against 187 industry peers in the Health Care Equipment & Supplies industry. ZIMV has a bad profitability rating. Also its financial health evaluation is rather negative. ZIMV has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year ZIMV was profitable.
In the past year ZIMV had a positive cash flow from operations.
ZIMV had negative earnings in each of the past 5 years.
In the past 5 years ZIMV always reported a positive cash flow from operatings.
1.2 Ratios
ZIMV's Return On Assets of -51.93% is on the low side compared to the rest of the industry. ZIMV is outperformed by 69.35% of its industry peers.
ZIMV has a Return On Equity of -104.07%. This is in the lower half of the industry: ZIMV underperforms 67.74% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -51.93% | ||
| ROE | -104.07% | ||
| ROIC | N/A |
ROA(3y)-13.91%
ROA(5y)-10.45%
ROE(3y)-37.01%
ROE(5y)-24.95%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 64.25%, ZIMV is in the better half of the industry, outperforming 65.05% of the companies in the same industry.
ZIMV's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for ZIMV so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 64.25% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.14%
GM growth 5Y-0.53%
2. Health
2.1 Basic Checks
ZIMV does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ZIMV has been increased compared to 1 year ago.
ZIMV has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.08, we must say that ZIMV is in the distress zone and has some risk of bankruptcy.
ZIMV has a Altman-Z score (1.08) which is in line with its industry peers.
The Debt to FCF ratio of ZIMV is 9.47, which is on the high side as it means it would take ZIMV, 9.47 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 9.47, ZIMV is doing good in the industry, outperforming 74.19% of the companies in the same industry.
A Debt/Equity ratio of 0.60 indicates that ZIMV is somewhat dependend on debt financing.
ZIMV has a worse Debt to Equity ratio (0.60) than 69.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.6 | ||
| Debt/FCF | 9.47 | ||
| Altman-Z | 1.08 |
ROIC/WACCN/A
WACC9.08%
2.3 Liquidity
ZIMV has a Current Ratio of 1.94. This is a normal value and indicates that ZIMV is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.94, ZIMV is not doing good in the industry: 72.58% of the companies in the same industry are doing better.
A Quick Ratio of 1.43 indicates that ZIMV should not have too much problems paying its short term obligations.
ZIMV has a Quick ratio of 1.43. This is in the lower half of the industry: ZIMV underperforms 68.82% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.94 | ||
| Quick Ratio | 1.43 |
3. Growth
3.1 Past
ZIMV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -63.55%.
ZIMV shows a small growth in Revenue. In the last year, the Revenue has grown by 0.15%.
The Revenue for ZIMV have been decreasing by -16.08% on average. This is quite bad
EPS 1Y (TTM)-63.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-23.53%
Revenue 1Y (TTM)0.15%
Revenue growth 3Y-20.56%
Revenue growth 5Y-16.08%
Sales Q2Q%-48.06%
3.2 Future
The Earnings Per Share is expected to grow by 15.02% on average over the next years. This is quite good.
The Revenue is expected to decrease by -18.83% on average over the next years. This is quite bad
EPS Next Y-1.82%
EPS Next 2Y11.7%
EPS Next 3Y15.02%
EPS Next 5YN/A
Revenue Next Year-47.81%
Revenue Next 2Y-27.3%
Revenue Next 3Y-18.83%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
ZIMV is valuated quite expensively with a Price/Earnings ratio of 39.85.
Based on the Price/Earnings ratio, ZIMV is valued a bit cheaper than 70.97% of the companies in the same industry.
ZIMV is valuated rather expensively when we compare the Price/Earnings ratio to 30.72, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 20.76 indicates a rather expensive valuation of ZIMV.
83.33% of the companies in the same industry are more expensive than ZIMV, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of ZIMV to the average of the S&P500 Index (22.18), we can say ZIMV is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 39.85 | ||
| Fwd PE | 20.76 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ZIMV is valued cheaper than 89.78% of the companies in the same industry.
ZIMV's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ZIMV is cheaper than 91.94% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.26 | ||
| EV/EBITDA | 11.62 |
4.3 Compensation for Growth
A more expensive valuation may be justified as ZIMV's earnings are expected to grow with 15.02% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.7%
EPS Next 3Y15.02%
5. Dividend
5.1 Amount
No dividends for ZIMV!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ZIMVIE INC
NASDAQ:ZIMV (10/8/2024, 4:30:02 PM)
After market: 15.54 0 (0%)15.54
+0.11 (+0.71%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap428.44M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 39.85 | ||
| Fwd PE | 20.76 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -51.93% | ||
| ROE | -104.07% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 64.25% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.13
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.6 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.94 | ||
| Quick Ratio | 1.43 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-63.55%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-1.82%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)0.15%
Revenue growth 3Y-20.56%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y